NCT00427128View on ClinicalTrials.gov

Prozac Treatment of Major Depression: Discontinuation Study

PHASE4CompletedINTERVENTIONAL
Enrollment

627

Participants

Timeline

Start Date

November 30, 1995

Study Completion Date

March 31, 2003

Conditions
Major Depression
Interventions
DRUG

fluoxetine

10mg/day increased over 12 weeks to 20-80 mg/day; 20-80 mg/day maintained from week 13-36.

DRUG

placebo

Week 13-36.

Trial Locations (2)

10032

New York State Psychiatric Institute, New York

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
collaborator

Massachusetts General Hospital

OTHER

lead

New York State Psychiatric Institute

OTHER

NCT00427128 - Prozac Treatment of Major Depression: Discontinuation Study | Biotech Hunter | Biotech Hunter